Search

Showing 51 - 60 of 463 results.

Patients who benefit

Guler N, Ozkara C, Akyol A. Left ventricular outflow tract obstruction after bioprosthetic mitral valve replacement with posterior mitral leaflet preservation. Tex Heart Inst J. 2006;33(3):39
Clinical Data

EXCELLENT OUTCOMES IN CLINICAL TRIAL RESULTS FIND OUT MORE: Clinical trials CLINICAL INSIGHTS 30-DAY NAVITOR™1,2 N=120 EVOLUT‡ PRO3 N=60 ACURATE NEO2‡4
Clinical Data

Tendyne™ TMVR improves your patients’ function and quality of life, with clinically significant improvement in a 6-minute walk test2 and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores.1 The
Patients who benefit

PATIENTS WHO BENEFIT MR IS THE MOST COMMON VALVULAR HEART DISEASE AND IS SIGNIFICANTLY UNDERTREATED3 More patients are suffering from MR than any other valve disease, and only a small percentage of
Clinical Data

INSPIRED BY PATIENTS. MADE POSSIBLE BY YOU. TriClip TEER has shown meaningful outcomes in both real-world and randomized clinical data. The bRIGHT study and TRILUMINATE™ Pivotal trial demonstrated
Features

The TriClip™ G4 Transcatheter Edge-to-Edge Repair System empowers you with stable navigation and precise delivery2 for complex conditions.
Patients who benefit

A STATE-OF-THE-ART TREATMENT OPTION FOR PATIENTS AT HIGH RISK FOR SURGERY TriClip™ TEER is a low risk,5 minimally invasive, non-surgical treatment option for symptomatic patients with severe Tricuspi
Overview

WATCH HOW TRICLIP™ TEER TRANSFORMED CRUZ'S LIFE FIND OUT MORE: DOWNLOAD FLYER FIND OUT MORE: TRICUSPID REGURGITATION TREATMENT OPTIONS CLINICAL DATA PCR L
Overview

WATCH HOW MITRACLIP™ TEER TRANSFORMED LUCA'S LIFE FIND OUT MORE: DOWNLOAD FLYER *The testimonial does not provide any indication, guide, warranty or guarantee as to the response patients may ha